CA-LIGHTBITS-LABS
Lightbits Labs today announced advancements to its cloud-native storage solution, enabling customers to confidently scale their private, hybrid, and edge cloud deployments. Lightbits, recently backed by Intel Capital , has extended its solution’s capabilities with the delivery of LightOS™ 2.1. This release further enhances high-performance, scalability, and low latency. Today’s news underpins the Lightbits vision of enabling organizations to unleash hyperscale storage for private clouds, but at a fraction of the cost of even the most advanced cloud storage offerings. LightOS 2.1 further enhances QoS for logical volumes during drive failure recoveries, multi-tenancy capabilities and adds directed-availability of snapshots and thin clones.
The new age of 5G, IoT, AI and ML and ever-increasing analytic data, calls for cloud-optimized block storage volumes that support higher IOPS, higher bandwidth and sub-millisecond, low-variance I/O latency. Like the Amazon EBS io2 Block Express volumes , which was recently announced at the AWS Re:Invent conference, Lightbits Labs’ LightOS provides high-performance, low-latency block storage volumes for on-prem cloud native application environments.
“Lightbits realized early on that disaggregated, high-performance software defined storage that utilized standard Ethernet networking is what would drive successful on-premises cloud deployments,” said Avigdor Willenz, co-founder and chairman of Lightbits Labs and previously co-founder of Annapurna Labs, acquired by Amazon in 2015. “The new Amazon EBS io2 Block Express volumes utilize scalable reliable datagrams that are implemented using custom-built, dedicated hardware. We specifically developed LightOS and NVMe/TCP to avoid the need for special network hardware yet provide a level of performance similar to local NVMe.”
As AWS extends its infrastructure offerings to hybrid cloud with its Outpost offerings, it’s clear that the future of scalable infrastructure is in native cloud practices regardless of where cloud is deployed. For private, hybrid and edge cloud deployments, Lightbits’ LightOS delivers the same or better performance than the latest Amazon EBS io2 Block Express volumes at lower cost. “This enables us to bring high-performance infrastructure for all data centers with our key Intel product portfolio,” said Remi El-Ouazzane, Vice President and Data Platforms Group Chief Strategy and Business Development Officer at Intel. “Given our recent partnership with Lightbits, we’ve had strong customer momentum in the space of disaggregated storage over TCP with customers deploying the solution in production on bare metal edge, enterprise private cloud (financial), and multi-tenancy Kubernetes-based environment for cloud service providers.”
LightOS scale out disaggregated storage solution is perfect for the largest, most performance-sensitive cloud native applications with improved price-performance, ease-of-implementation, availability and scalability. Further, as AWS is now announcing with EBS Gp3 volumes, LightOS has always decoupled IOPS from storage capacity and allowed for independent scaling of storage and compute. When combining this level of performance and flexibility along with other standard features such as thin provisioning, compression, snapshots and thin clones and the ability to utilize and extend the endurance of any flash, including QLC SSDs, it delivers EBS-like “Hyperscale Storage for All” for enterprise private clouds.
Intel’s Remi El-Ouazzane further states: “Our work with Lightbits to optimize the joint solution around Intel® Xeon® Scalable Processors, Optane™ Persistent Memory, 3D NAND QLC SSDs, and Intel® Ethernet 800 Series network adapters has delivered improved performance and TCO for our customer ecosystem.”
LightOS 2.1 is available immediately and offers better performance, scalability and latency than the most advanced cloud offerings for private clouds. With a fully programmatic API, and integration with Kubernetes and OpenStack, and the choice of software-only or a fully integrated and ready-to-run appliance, Lightbits Labs’ LightOS is ready to unleash the full power of private, hybrid and edge clouds for the next 10 years of cloud architecture.
Lightbits Labs Resources
- IDC Research: NVMe/TCP Enables the Democratization of Disaggregated NVMe-based Storage
- Lightbits Labs Hyperscale Storage for All Video
- LightOS 2.0 Product Overview: Software-Defined Composable Storage
- Kubernetes and LightOS: Performance, Persistence, Simplicity
- Apache Kafka and LightOS
About Lightbits Labs™
Lightbits Labs “Hyperscale Storage for All” delivers composable NVMe/TCP storage that enables on-premise, hybrid cloud, and cloud native environments to independently scale storage from compute thereby unleashing hyperscale flexibility while lowering cost and performing like local flash. The highly available software-defined storage maximizes utilization, helping customers maintain operational efficiency and easily scale their business.
Founded in 2016, Lightbits pioneered NVMe/TCP and delivered the industry’s first NVMe/TCP storage solution. Lightbits is backed by strategic investors including Intel Capital, Dell Technologies Capital, Cisco Investments, and Micron, as well as top investors and VCs including Avigdor Willenz, Lip-Bu Tan, Marius Nacht, SquarePeg Capital, and WRVI Capital. Learn more at www.lightbitslabs.com or contact us at info@lightbitslabs.com .
Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201209005065/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 00:34:00 CET | Press release
Announcement of Enry’s Island AdVentures: the world’s first video game to learn how to launch and scale startups, focused on democratizing innovation for “Long Tail Users” Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 21:37:00 CET | Press release
Part of the Digital Morocco 2030 strategy, 500 Global has been selected to support the Startup Venture Building (Startup VB) initiative. 500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to streng
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press release
New capital accelerates Neural Concept’s ability to deliver transformative technologies and enterprise-wide AI impact across advanced industrial workflows.Platform delivers CAD-native, physics-aware AI and deep reasoning for engineering, saving customers $50 million annually, reducing late-stage redesigns by 30-50% and accelerating time to market by up to two years.The company has generated a fourfold increase in enterprise revenue over the past 18 months.More than 50 global companies are actively relying on the platform, including General Motors, General Electric Vernova, Leonardo Aerospace, Eaton, Safran, Renault Group and multiple Formula 1 teams. Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special?MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
